Effects of erythromycin on hepatic drug-metabolizing enzymes in humans
about
Lack of pharmacokinetic interaction between tiagabine and erythromycin.Review and comparison of advanced-generation macrolides clarithromycin and dirithromycin.Idiosyncratic drug reactions: a mechanistic evaluation of risk factorsHallucinations after a therapeutic dose of benzodiazepine hypnotics with co-administration of erythromycin.Diltiazem inhibits human intestinal cytochrome P450 3A (CYP3A) activity in vivo without altering the expression of intestinal mRNA or protein.The cyclosporin-erythromycin interaction: impaired first pass metabolism in the pigDrug bioactivation, covalent binding to target proteins and toxicity relevance.Functional polymer-dependent 3D culture accelerates the differentiation of HepaRG cells into mature hepatocytes.The theophylline-erythromycin interaction.Erythromycin-induced drug interactions. An illustrative case and review of the literature.Drug-mediated inactivation of cytochrome P450.Inhibitory effects of amiodarone and its N-deethylated metabolite on human cytochrome P450 activities: prediction of in vivo drug interactionsEvaluation of a potential interaction between erythromycin and glyburide in diabetic volunteers.In-vivo kinetics of the interaction between midazolam and erythromycin in rats, taking account of metabolic intermediate complex formation.Erythromycin toxicity in primary cultures of rat hepatocytes.
P2860
Q33488034-B7B60AD9-AE57-4475-B77F-7B8B9F19D85BQ33598839-C9B590DB-EFCE-4E5D-9832-8983ED13BFE1Q34403403-DC4DB60C-FB02-4CC8-A4F3-004458B79FECQ34414908-AD570295-ECA3-4118-9460-4FEF5F5EB619Q35826861-85B5BBEA-CC95-4BA7-8F02-74883904EC94Q35871139-BA3640D4-28A1-457F-B73A-32AA7FEA973AQ36061821-8EC8CDA6-71F8-480A-9ECC-26A1592103CCQ38807048-BD2C4CF4-3AC7-40BE-B547-707A515B9818Q39535007-CC31B58C-2F11-4AAE-AA77-3599EF3251B4Q39803080-03E2785B-90E2-48C0-A928-119AB18EFBB9Q41555359-8F2B1895-D16F-4192-A0FE-3F35B2122A33Q41610270-5240A8FE-A47F-495E-ADD7-72DFBE838ABFQ41919206-254514A2-1454-4C0A-906B-024CC77E0C3EQ43615884-FA274496-B892-45C6-A152-92B5EDC47186Q54124727-4CCA4DA1-3498-4155-A41C-D213929D5B2C
P2860
Effects of erythromycin on hepatic drug-metabolizing enzymes in humans
description
im März 1983 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 March 1983
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в березні 1983
@uk
name
Effects of erythromycin on hepatic drug-metabolizing enzymes in humans
@en
Effects of erythromycin on hepatic drug-metabolizing enzymes in humans
@nl
type
label
Effects of erythromycin on hepatic drug-metabolizing enzymes in humans
@en
Effects of erythromycin on hepatic drug-metabolizing enzymes in humans
@nl
prefLabel
Effects of erythromycin on hepatic drug-metabolizing enzymes in humans
@en
Effects of erythromycin on hepatic drug-metabolizing enzymes in humans
@nl
P2093
P1476
Effects of erythromycin on hepatic drug-metabolizing enzymes in humans
@en
P2093
P304
P356
10.1016/0006-2952(83)90626-3
P407
P577
1983-03-01T00:00:00Z